hyaluronidase
RxNorm concept 5464, ingredient (in).
- RxCUI
- 5464
- Term type
- Ingredient (IN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/5464 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- Amphadase (BN, has tradename)
- Hylenex (BN, has tradename)
- Rituxan Hycela (BN, has tradename)
- Herceptin Hylecta (BN, has tradename)
- Darzalex Faspro (BN, has tradename)
- Phesgo (BN, has tradename)
- Vyvgart Hytrulo (BN, has tradename)
- Ocrevus Zunovo (BN, has tradename)
- Tecentriq Hybreza (BN, has tradename)
- Opdivo Qvantig (BN, has tradename)
- Rybrevant Faspro (BN, has tradename)
- hyaluronidase, bovine 150 UNT/ML (SCDC, ingredient of)
- hyaluronidase Injectable Product (SCDG, ingredient of)
- hyaluronidase, human recombinant 160 UNT/ML (SCDC, ingredient of)
- hyaluronidase Injection (SCDF, ingredient of)
- hyaluronidase, human recombinant 150 UNT/ML (SCDC, ingredient of)
- hyaluronidase, human recombinant 2000 UNT/ML (SCDC, ingredient of)
- hyaluronidase / rituximab Injectable Product (SCDG, ingredient of)
- hyaluronidase / rituximab Injection (SCDF, ingredient of)
- hyaluronidase / trastuzumab Injectable Product (SCDG, ingredient of)
- hyaluronidase / trastuzumab Injection (SCDF, ingredient of)
- hyaluronidase-oysk 2000 UNT/ML (SCDC, ingredient of)
- hyaluronidase-fihj 2000 UNT/ML (SCDC, ingredient of)
- daratumumab / hyaluronidase Injectable Product (SCDG, ingredient of)
- daratumumab / hyaluronidase Injection (SCDF, ingredient of)
- hyaluronidase-zzxf 2000 UNT/ML (SCDC, ingredient of)
- hyaluronidase / pertuzumab / trastuzumab Injectable Product (SCDG, ingredient of)
- hyaluronidase / pertuzumab / trastuzumab Injection (SCDF, ingredient of)
- hyaluronidase-qvfc 2000 UNT/ML (SCDC, ingredient of)
- efgartigimod alfa / hyaluronidase Injectable Product (SCDG, ingredient of)
- efgartigimod alfa / hyaluronidase Injection (SCDF, ingredient of)
- hyaluronidase-ocsq 1000 UNT/ML (SCDC, ingredient of)
- hyaluronidase / ocrelizumab Injectable Product (SCDG, ingredient of)
- hyaluronidase / ocrelizumab Injection (SCDF, ingredient of)
- hyaluronidase-tqjs 2000 UNT/ML (SCDC, ingredient of)
- atezolizumab / hyaluronidase Injectable Product (SCDG, ingredient of)
- atezolizumab / hyaluronidase Injection (SCDF, ingredient of)
- hyaluronidase-nvhy 2000 UNT/ML (SCDC, ingredient of)
- hyaluronidase / nivolumab Injectable Product (SCDG, ingredient of)
- hyaluronidase / nivolumab Injection (SCDF, ingredient of)
- efgartigimod alfa / hyaluronidase Prefilled Syringe (SCDF, ingredient of)
- hyaluronidase-lpuj 2000 UNT/ML (SCDC, ingredient of)
- amivantamab / hyaluronidase Injectable Product (SCDG, ingredient of)
- amivantamab / hyaluronidase Injection (SCDF, ingredient of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 5464 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/5464 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 5464. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.